Castlight Health, inc. (NYSE:CSLT) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Wednesday.

A number of other research analysts have also recently weighed in on CSLT. ValuEngine cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Friday, May 19th. Chardan Capital initiated coverage on shares of Castlight Health, inc. in a report on Tuesday, June 6th. They issued a “buy” rating and a $4.50 price objective for the company. Zacks Investment Research upgraded shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th. Cowen and Company restated a “market perform” rating and issued a $4.50 price objective (up previously from $4.00) on shares of Castlight Health, inc. in a report on Thursday, August 3rd. Finally, Dougherty & Co restated a “buy” rating on shares of Castlight Health, inc. in a report on Thursday, August 17th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. Castlight Health, inc. has a consensus rating of “Hold” and an average price target of $4.57.

Shares of Castlight Health, inc. (CSLT) opened at 4.10 on Wednesday. Castlight Health, inc. has a 12 month low of $3.05 and a 12 month high of $5.50. The stock has a 50 day moving average of $4.00 and a 200 day moving average of $3.88. The stock’s market cap is $539.92 million.

Castlight Health, inc. (NYSE:CSLT) last announced its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.02. The firm had revenue of $32.10 million during the quarter, compared to analysts’ expectations of $31.14 million. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 36.30%. The business’s quarterly revenue was up 36.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.11) earnings per share. On average, equities analysts anticipate that Castlight Health, inc. will post ($0.25) earnings per share for the current fiscal year.

WARNING: “Castlight Health, inc. (CSLT) Rating Increased to Sell at BidaskClub” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/13/castlight-health-inc-cslt-rating-increased-to-sell-at-bidaskclub.html.

In other Castlight Health, inc. news, CFO Mangini Siobhan Nolan sold 28,639 shares of the business’s stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $3.66, for a total transaction of $104,818.74. Following the completion of the transaction, the chief financial officer now owns 41,622 shares in the company, valued at approximately $152,336.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO John C. Doyle sold 35,184 shares of the business’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $3.65, for a total transaction of $128,421.60. Following the transaction, the chief executive officer now owns 75,639 shares of the company’s stock, valued at approximately $276,082.35. The disclosure for this sale can be found here. Insiders have sold a total of 208,287 shares of company stock valued at $795,240 in the last quarter. 24.38% of the stock is currently owned by company insiders.

Several large investors have recently modified their holdings of the company. FMR LLC lifted its position in shares of Castlight Health, inc. by 49.2% during the 2nd quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock worth $47,451,000 after buying an additional 3,768,009 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Castlight Health, inc. by 36.0% during the 2nd quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock worth $15,094,000 after buying an additional 963,188 shares during the last quarter. Prudential PLC lifted its position in shares of Castlight Health, inc. by 23.5% during the 2nd quarter. Prudential PLC now owns 2,002,706 shares of the software maker’s stock worth $8,311,000 after buying an additional 380,920 shares during the last quarter. Gagnon Securities LLC lifted its position in shares of Castlight Health, inc. by 2.5% during the 1st quarter. Gagnon Securities LLC now owns 1,446,792 shares of the software maker’s stock worth $5,281,000 after buying an additional 35,374 shares during the last quarter. Finally, Maverick Capital Ltd. lifted its position in shares of Castlight Health, inc. by 2.8% during the 2nd quarter. Maverick Capital Ltd. now owns 1,221,809 shares of the software maker’s stock worth $5,071,000 after buying an additional 33,735 shares during the last quarter. Institutional investors and hedge funds own 41.30% of the company’s stock.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Stock Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related stocks with our FREE daily email newsletter.